Abstract
This research characterized the organic extracts of Capsicum chinense by GCMS and LCMS analyses and investigated their antidiabetic potentials in a fructose-fed streptozotocin (STZ)-induced model. The organic extracts were found to display a promising in vitro inhibition of α-amylase and α-glucosidase and in vivo decrease of serum glucose levels, ALP, ALT, AST, creatinine, uric acid, and lipid levels. They upregulated the antioxidative CAT, SOD1, GPx, and PFK1 gene expressions and restored the pancreas, liver, and kidney architectures. Multitarget interactions of C. chinense metabolites forcibly modulated the AKT1 and PIK3R1 proteins demonstrating the prospective functional food potential of C. chinense.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
